Eli Lilly has Launched Zepbound in U.S. Pharmacies. The company enters the booming weight-loss market with a potential $2 billion sales projection. NTD’s Stephanie Sical reports.
Eli Lilly Projects $2 Billion In Sales for 2024
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
Stay informed with accurate news you can trust.
Success! You are now subscribed.
By registering for the newsletter, you agree to the Privacy Policy.